Neuropsicofarmacología
![Foto de Neuropsicofarmacología](/img/uploaded/133B5DEFC4D194B6A12E03E329850F74.png)
![Foto de National Institutes of Health](/img/noimage_org.png)
National Institutes of Health
Bethesda, Estados UnidosNational Institutes of Health-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2021
-
Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia
Neuropsychopharmacology, Vol. 46, Núm. 3, pp. 665-672